Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs
synthonicsinc.com

See what CB Insights has to offer

Total Raised

$7.97M

Investors Count

1

Deal Terms

2

Synthonics Funding, Synthonics Valuation & Synthonics Revenue

6 Fundings

Synthonics's latest funding round was a Corporate Minority for $2M on April 16, 2015.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

4/16/2015

Corporate Minority

$2M

$0.00B

((9.99x))

FY 1234

1

7/28/2014

Unattributed - III

$99M

$0.00B

((9.99x))

FY 1234

10

8/10/2010

Unattributed - II

$99M

$0.00B

((9.99x))

FY 1234

10

8/27/2009

Unattributed

$99M

$0.00B

((9.99x))

FY 1234

10

2/1/2008

Series B

$99M

$0.00B

((9.99x))

FY 1234

10

Date

4/16/2015

7/28/2014

8/10/2010

8/27/2009

2/1/2008

Round

Corporate Minority

Unattributed - III

Unattributed - II

Unattributed

Series B

Amount

$2M

$99M

$99M

$99M

$99M

Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

1

10

10

10

10

Synthonics Deal Terms

2 Deal Terms

Synthonics's deal structure is available for 2 funding rounds, including their Series B from February 01, 2008.

Round

Series B

Series A

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$99M

$99M

$99M

$99M

Series A

Synthonics Investors

1 Investors

Synthonics has 1 investors. Recipharm invested in Synthonics's Corporate Minority funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

4/16/2015

4/16/2015

1
Corporate Minority

Corporation

Sweden

First funding

4/16/2015

Last Funding

4/16/2015

Investor

Rounds

1
Corporate Minority

Board Seats

Type

Corporation

Location

Sweden

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.